×
About 338 results

ALLMedicine™ Onycholysis Center

Research & Reviews  94 results

Retronychia
https://www.merckmanuals.com/professional/dermatologic-disorders/nail-disorders/retronychia

Dec 1st, 2021 - Retronychia is a less common form of paronychia, which is infection of the periungual tissues. Acute symptoms include pain, inflammation of the proximal nail fold, xanthonychia, onycholysis, and granulation tissue. Chronic retronychia is character...

Psoriatic Arthritis
http://emedicine.medscape.com/article/331037-clinical

Nov 2nd, 2021 - Practice Essentials Psoriatic arthritis is most commonly a seronegative oligoarthritis found in patients with psoriasis, with less common, but characteristic, differentiating features of distal joint involvement and arthritis mutilans. [1] One in ...

Psoriatic Arthritis
http://emedicine.medscape.com/article/331037-overview

Nov 2nd, 2021 - Practice Essentials Psoriatic arthritis is most commonly a seronegative oligoarthritis found in patients with psoriasis, with less common, but characteristic, differentiating features of distal joint involvement and arthritis mutilans. [1] One in ...

Application of Topical Lidocaine for Pain Relief in the Setting of Targeted Therapy-Ind...
https://doi.org/10.1089/jpm.2021.0197
Journal of Palliative Medicine; Bromberg H, Chang Y et. al.

Sep 23rd, 2021 - Selective pan fibroblast growth factor receptor (FGFR) inhibitors have been linked to severe onycholysis, the uncomfortable separation of the nail plate from the nail bed. Recommendations to assist with FGFR inhibitor onycholysis vary based on the...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  7 results

Evaluation of Cryoprotection Induced Nail Toxicity Docetaxel Low Cumulative Dose
https://clinicaltrials.gov/ct2/show/NCT02283983

Aug 28th, 2020 - For the specific patient population studied receiving 5-Fluorouracil, epirubicin and cyclophosphamide - Docetaxel sequence (cumulative dose <300 mg / m2), using a cryoprotection has never been assessed. The effectiveness of cryoprotection of onych...

The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer Patients
https://clinicaltrials.gov/ct2/show/NCT03173365

Jan 9th, 2019 - Hand-foot syndrome (HFS) is an adverse event frequently associated with the use of classical chemotherapeutic agents such as capecitabine or pegylated liposomal doxorubicin, as well as targeted cancer drugs such as sorafenib or other tyrosine-kina...

A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis
https://clinicaltrials.gov/ct2/show/NCT02670603

Apr 28th, 2017 - This study is a prospective randomized controlled study of EVONAIL® solution for prevention or treatment of onycholysis in patients with breast cancer receiving docetaxel chemotherapy.

A Study of Gemzar, Taxotere, and Xeloda for Adjuvant Pancreatic Cancer
https://clinicaltrials.gov/ct2/show/NCT00882310

Jul 25th, 2016 - The adjuvant treatment of resected pancreatic cancer is currently in flux. Many in the United States continue to use 5FU-based chemotherapy with radiation to the pancreatic bed. Some in the States, and most investigators in Europe, use a 5FU based...

Distal Erosions and Nail Psoriasis
https://clinicaltrials.gov/ct2/show/NCT02813720

Jun 28th, 2016 - Nearly 30% of patients with cutaneous psoriasis (PsO) developed psoriatic arthritis (PsA). Among these patients 20 % will have severe destructive arthritis. The risk of developing PsA is significantly higher in patients with nail involvement (OR =...

see more →

News  29 results

Tagawa Breaks Down FGFR Testing and the Use of Erdafitinib in Bladder Cancer
https://www.onclive.com/view/tagawa-breaks-down-fgfr-testing-and-the-use-of-erdafitinib-in-bladder-cancer

Nov 8th, 2021 - Welcome to OncLive On Air®! I’m your host today, Jessica Hergert.  OncLive On Air® is a podcast from OncLive®, which provides oncology professionals with the resources and information they need to provide the best patient care. In both digital an...

Review eyes nail unit toxicities secondary to targeted cancer therapy
https://www.mdedge.com/dermatology/article/244613/hair-nails/review-eyes-nail-unit-toxicities-secondary-targeted-cancer
Doug Brunk

Aug 24th, 2021 - Paronychia and periungual pyogenic granulomas are the most common nail unit toxicities related to targeted cancer therapies and immunotherapies, while damage to other nail unit anatomic areas can be wide-ranging. Those are key findings from an evi.

Review Eyes Nail Unit Toxicities Secondary to Targeted Cancer Therapy
https://www.medscape.com/viewarticle/957155

Aug 24th, 2021 - Paronychia and periungual pyogenic granulomas are the most common nail unit toxicities related to targeted cancer therapies and immunotherapies, while damage to other nail unit anatomic areas can be wide-ranging. Those are key findings from an evi...

Psoriasis Treatment With Biologics: 5 Things to Know
https://www.medscape.com/viewarticle/951993

Jun 14th, 2021 - Psoriasis affects at least 100 million people worldwide, with plaque psoriasis (also referred to as psoriasis vulgaris) being the most common form. Although many different medication options are available for psoriasis, the type of treatment presc...

FGFR Inhibitors for Advanced Cholangiocarcinoma: Adverse Events
https://www.onclive.com/view/fgfr-inhibitors-for-advanced-cholangiocarcinoma-adverse-events

Apr 19th, 2021 - John L. Marshall, MD: Let’s pause to carve these out and talk about the FGFR space. I wasn’t thinking about resistance mechanisms and new drugs to chase that, but back when we were just treating GISTs [gastrointestinal stromal tumors], I thought t...

see more →

Patient Education  1 results see all →